Colorectal cancer detection and treatment with engineered probiotics
Candice R. Gurbatri(Tempus Labs (United States)), Tal Danino(Herbert Irving Comprehensive Cancer Center), YoungUk Jang(Icahn School of Medicine at Mount Sinai), Tarik Sammour(Royal Adelaide Hospital), Ioana Lia(Columbia University), Laura Vrbanac(The University of Adelaide), Fereshteh Zandkarimi(Columbia University), E Thomas(The University of Adelaide), Georgette Radford(The University of Adelaide), Susan L. Woods(South Australian Health and Medical Research Institute), Amanda Lim(The University of Adelaide), Courtney Coker(Columbia University), Julie Marker(SA Health), Jongwon Im(Columbia University), Josephine A. Wright(The University of Adelaide), Tamsin R.M. Lannagan(South Australian Health and Medical Research Institute), Anas A. Saleh(Cornell University), Ayelet Sivan(University of Chicago), Cheri Ostroff(University of South Australia), Nicholas Arpaia(Columbia University Irving Medical Center), Hiroki Kobayashi(Columbia University Irving Medical Center), Matt Lawrence(Royal Adelaide Hospital), Kyu Y. Rhee(Cornell University), Patricia Kaazan(The University of Adelaide), Joanne Perry(Royal Adelaide Hospital), Tiffany Chien(Columbia University), Tracy Fitzsimmons(Royal Adelaide Hospital), Samuel Taylor(Cornell University), Geraint B. Rogers(South Australian Health and Medical Research Institute), Tongtong Wang(Shandong Agricultural University), Jia Q. Ng(The University of Adelaide), Mark Lewis(Royal Adelaide Hospital), Lito E. Papanicolas(Flinders University), Michelle Thomas(Royal Adelaide Hospital), Daniel L. Worthley(Brisbane Hand & Upper Limb Research Institute)
Cited by 3
Related Papers
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
|Science Translational Medicine|2020|600
Engineering bacteria as interactive cancer therapies
|Science|2022|411